References
- Ashworth TR (1869). A case of cancer in which cells similar to those in the tumours were seen in the blood after death. 14,146-149.
- Begg CB (1994). Publication bias. 25, 299-409.
- Castaldo G, Tomaiuolo R, Sanduzzi A, et al (1997). Lung cancer metastatic cells detected in blood by reverse transcriptasepolymerase chain reaction and dot-blot analysis. J Clin Oncol, 15, 3388-93.
- Chen TF, Jiang GL, Fu XL, et al (2007). CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancertreated by chemo-radiation: an independent prognostic factor. Lung Cancer, 56, 105-14. https://doi.org/10.1016/j.lungcan.2006.11.006
- Cohen SJ, Punt CJ, Iannotti N, et al (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 26, 3213-21. https://doi.org/10.1200/JCO.2007.15.8923
- Cristofanilli M (2006). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol, 33, S9-14.
- Devriese LA, Bosma AJ, de Heuvel MM, v Heemsbergen W, Voest EE, Schellens JH (2012). Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer, 75, 242-7. https://doi.org/10.1016/j.lungcan.2011.07.003
- Farace F, Massard C, Vimond N, et al (2011). A direct comparison of CellSearch and ISET for circulating tumourcell detection in patients with metastatic carcinomas. Br J Cancer, 105, 847-53. https://doi.org/10.1038/bjc.2011.294
- Guo Y, Wang J, Huang P (2009). [Clinical Significance of CK20, CK19, CEA mRNAs in Peripheral Blood from Lung Cancer Patients.]. Zhongguo Fei Ai Za Zhi, 12, 1013-7.
- Hayes DC, Secrist H, Bangur CS, et al (2006). Multigene realtime PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res, 26, 1567-75.
- Hayes DF, Isaacs C, Stearns V (2001). Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia, 6, 375-92. https://doi.org/10.1023/A:1014778713034
- Hedges LV, Vevea JL (1998). Fixed-and random-effects models in meta-analysis. Psychol Methods, 3, 486. https://doi.org/10.1037/1082-989X.3.4.486
- Helo P, Cronin AM, Danila DC, et al (2009). Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem, 55, 765-73. https://doi.org/10.1373/clinchem.2008.117952
- Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
- Hofman V, Bonnetaud C, Ilie MI, et al (2011). Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res, 17, 827-35. https://doi.org/10.1158/1078-0432.CCR-10-0445
- Hofman V, Ilie MI, Long E, et al (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer, 129, 1651-60. https://doi.org/10.1002/ijc.25819
- Hofman V, Long E, Ilie M, et al (2012). Morphological analysis of circulating tumour cells in patients undergoing surgeryfor non-small cell lung carcinoma using the isolation by size of epithelialtumour cell (ISET) method. Cytopathology, 23, 30-8. https://doi.org/10.1111/j.1365-2303.2010.00835.x
- Hofman V, Long E, Ilie M, et al (2012). Morphological analysis of circulating tumour cells in patients undergoing surgeryfor non-small cell lung carcinoma using the isolation by size of epithelialtumour cell (ISET) method. Cytopathology, 23, 30-8. https://doi.org/10.1111/j.1365-2303.2010.00835.x
- Hou JM, Greystoke A, Lancashire L, et al (2009). Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol, 175, 808-16. https://doi.org/10.2353/ajpath.2009.090078
- Hou JM, Krebs M, Ward T, et al (2011). Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol, 178, 989-96. https://doi.org/10.1016/j.ajpath.2010.12.003
- Hou JM, Krebs MG, Lancashire L, et al (2012). Clinical significance and molecular characteristics of circulating tumor cellsand circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol, 30, 525-32. https://doi.org/10.1200/JCO.2010.33.3716
- Huang TH, Wang Z, Li Q, Li FR, Qi H, Zhou HX (2007). [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads]. Zhonghua Zhong Liu Za Zhi, 29, 676-80.
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kim MY, Oskarsson T, Acharyya S, et al (2009). Tumor selfseeding by circulating cancer cells. Cell, 139, 1315-26. https://doi.org/10.1016/j.cell.2009.11.025
- Krebs MG, Sloane R, Priest L, et al (2011). Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol, 29, 1556-63. https://doi.org/10.1200/JCO.2010.28.7045
- Krebs MG, Sloane R, Priest L, et al (2011). Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol, 29, 1556-63. https://doi.org/10.1200/JCO.2010.28.7045
- Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K (1999). Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol, 17,19-24.
- Kurusu Y, Yamashita J, Ogawa M (1999). Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery, 126, 820-6. https://doi.org/10.1016/S0039-6060(99)70020-6
- Kurusu Y, Yamashita J, Ogawa M (1999). Detection of circulating tumor cells by reverse transcriptase-polymerase chainreaction in patients with resectable non-small-cell lung cancer. Surgery, 126, 820-6. https://doi.org/10.1016/S0039-6060(99)70020-6
- Labelle M, Begum S, Hynes RO (2011). Direct signaling between platelets and cancer cells induces an epithelial mesenchymal-like transition and promotes metastasis. Cancer Cell, 20, 576-90. https://doi.org/10.1016/j.ccr.2011.09.009
- Li J, Sun YE, Sheng QM, Yan LD, Lu XC (2005). [Detection of blood dissemination during the operation of lung cancer and its significance]. Zhonghua Wai Ke Za Zhi, 43, 76-9.
- Liu L, Liao GQ, He P, et al (2008). Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun, 372, 756-60. https://doi.org/10.1016/j.bbrc.2008.05.101
- Mocellin S, Hoon D, Ambrosi A, Nitti D, Rossi CR (2006). The prognostic value of circulating tumor cells in patients with melanoma: asystematic review and meta-analysis. Clin Cancer Res, 12,4605-13. https://doi.org/10.1158/1078-0432.CCR-06-0823
- Nieva J, Wendel M, Luttgen MS, et al (2012). High-definition imaging of circulating tumor cells and associated cellular eventsin non-small cell lung cancer patients: a longitudinal analysis. Phys Biol, 9, 016004. https://doi.org/10.1088/1478-3975/9/1/016004
- Okumura Y, Tanaka F, Yoneda K, et al (2009). Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg, 87, 1669-75. https://doi.org/10.1016/j.athoracsur.2009.03.073
- Pantel K, Alix-Panabieres C (2010). Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med, 16, 398-406. https://doi.org/10.1016/j.molmed.2010.07.001
- Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the publishedliterature for survival endpoints. Stat Med, 17, 2815-34. https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
- Peck K, Sher YP, Shih JY, et al (1998). Detection and quantitation of circulating cancer cells in the peripheral blood oflung cancer patients. Cancer Res, 58, 2761-5.
- Rahbari NN, Aigner M, Thorlund K, et al (2010). Metaanalysis shows that detection of circulating tumor cells indicates poorprognosis in patients with colorectal cancer. Gastroenterology, 138, 1714-26. https://doi.org/10.1053/j.gastro.2010.01.008
- Sawabata N, Okumura M, Utsumi T, et al (2007). Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg, 55, 189-92. https://doi.org/10.1007/s11748-007-0101-2
- Sher YP, Shih JY, Yang PC, et al (2005). Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res, 11, 173-9.
- Sheu CC, Yu YP, Tsai JR, et al (2006). Development of a membrane array-based multimarker assay for detection ofcirculating cancer cells in patients with non-small cell lung cancer. Int J Cancer, 119, 1419-26. https://doi.org/10.1002/ijc.21999
- Tanaka F, Yoneda K, Kondo N, et al (2009). Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res, 15, 6980-6. https://doi.org/10.1158/1078-0432.CCR-09-1095
- Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007). Practical methods for incorporating summary time-to-event data intometa-analysis. Trials, 8, 16. https://doi.org/10.1186/1745-6215-8-16
- Wang FB, Yang XQ, Yang S, et al (2011). A Higher Number of Circulating Tumor Cells (CTC) in Peripheral Blood Indicates Poor Prognosis in Prostate Cancer Patients - A Meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
- Wendel M, Bazhenova L, Boshuizen R, et al (2012). Fluid biopsy for circulating tumor cell identification in patients with earlyandlate- stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol, 9, 016005. https://doi.org/10.1088/1478-3967/9/1/016005
- Williamson PR, Smith CT, Hutton JL, Marson AG (2002). Aggregate data meta-analysis with time-to-event outcomes. Stat Med, 21, 3337-51. https://doi.org/10.1002/sim.1303
- Wu C, Hao H, Li L, et al (2009). Preliminary investigation of the clinical significance of detecting circulatingtumor cells enriched from lung cancer patients. J Thorac Oncol, 4, 30-6. https://doi.org/10.1097/JTO.0b013e3181914125
- Yamashita J, Matsuo A, Kurusu Y, et al (2002). Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg, 124, 299-305. https://doi.org/10.1067/mtc.2002.124370
- Yamashita JI, Kurusu Y, Fujino N, Saisyoji T, Ogawa M (2000). Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg, 119, 899-905. https://doi.org/10.1016/S0022-5223(00)70084-5
- Yoon SO, Kim YT, Jung KC, et al (2011). TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer, 71, 209-16. https://doi.org/10.1016/j.lungcan.2010.04.017
- Zhao S, Liu Y, Zhang Q, et al (2011). The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR inbreast cancer: a meta-analysis of published literature. Breast Cancer Res Treat, 130, 809-16. https://doi.org/10.1007/s10549-011-1379-4
Cited by
- Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer vol.14, pp.1, 2014, https://doi.org/10.1186/1471-2407-14-773
- Prognostic Role of Circulating Tumor Cells in Patients with Pancreatic Cancer: a Meta-analysis vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6015
- Circulating Tumor Cells are Associated with Bone Metastasis of Lung Cancer vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6369
- How to Explain the Contradiction of microRNA 200c Expression and Survival in Solid Tumors?: a Meta-analysis vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3687
- Patients with CD133-Negative Colorectal Liver Metastasis Have a Poor Prognosis After Hepatectomy vol.21, pp.6, 2014, https://doi.org/10.1245/s10434-014-3549-1
- Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis vol.35, pp.6, 2014, https://doi.org/10.1007/s13277-014-1731-5
- Carboxybetaine Methacrylate-Modified Nylon Surface for Circulating Tumor Cell Capture vol.6, pp.6, 2014, https://doi.org/10.1021/am500394j
- Cancer stem cell characteristics of circulating tumor cells vol.90, pp.8, 2014, https://doi.org/10.3109/09553002.2014.886798
- Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis vol.32, pp.5, 2015, https://doi.org/10.1007/s12032-015-0579-x
- Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-016-4796-5
- Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis vol.13, pp.9, 2018, https://doi.org/10.1371/journal.pone.0203758